ES506213A0 - Procedimiento para preparar derivados metilolados de cefale-xina - Google Patents

Procedimiento para preparar derivados metilolados de cefale-xina

Info

Publication number
ES506213A0
ES506213A0 ES506213A ES506213A ES506213A0 ES 506213 A0 ES506213 A0 ES 506213A0 ES 506213 A ES506213 A ES 506213A ES 506213 A ES506213 A ES 506213A ES 506213 A0 ES506213 A0 ES 506213A0
Authority
ES
Spain
Prior art keywords
cefale
xina
procedure
methylated derivatives
preparing methylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES506213A
Other languages
English (en)
Other versions
ES8206533A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neopharmed SpA
Crinos Industria Farmacobiologica SpA
Original Assignee
Neopharmed SpA
Crinos Industria Farmacobiologica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharmed SpA, Crinos Industria Farmacobiologica SpA filed Critical Neopharmed SpA
Publication of ES8206533A1 publication Critical patent/ES8206533A1/es
Publication of ES506213A0 publication Critical patent/ES506213A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES506213A 1980-10-13 1981-10-13 Procedimiento para preparar derivados metilolados de cefale-xina Granted ES506213A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT25267/80A IT1195762B (it) 1980-10-13 1980-10-13 Derivati idrosolubili della cefalexina e procedimento per la loro produzione

Publications (2)

Publication Number Publication Date
ES8206533A1 ES8206533A1 (es) 1982-08-16
ES506213A0 true ES506213A0 (es) 1982-08-16

Family

ID=11216176

Family Applications (1)

Application Number Title Priority Date Filing Date
ES506213A Granted ES506213A0 (es) 1980-10-13 1981-10-13 Procedimiento para preparar derivados metilolados de cefale-xina

Country Status (17)

Country Link
US (1) US4471115A (es)
EP (1) EP0049928B1 (es)
JP (1) JPS5767583A (es)
KR (1) KR880000691B1 (es)
AR (1) AR229035A1 (es)
AT (1) ATE35813T1 (es)
AU (1) AU548333B2 (es)
BE (1) BE890718A (es)
CA (1) CA1181741A (es)
DE (1) DE3176811D1 (es)
DK (1) DK451281A (es)
ES (1) ES506213A0 (es)
FR (1) FR2491927B1 (es)
IT (1) IT1195762B (es)
NO (1) NO813433L (es)
PT (1) PT73807B (es)
YU (1) YU246381A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102058853B1 (ko) * 2018-02-28 2019-12-24 브릿지바이오테라퓨틱스(주) 지질화 펩타이드의 수용성 염과 이의 제조 방법 및 용도
CA3094295A1 (en) * 2018-03-29 2019-10-03 S.I.S. Shulov Innovative Science Ltd. Pharmaceutical compositions for inhibiting inflammatory cytokines
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1265315A (es) * 1968-04-05 1972-03-01 Glaxo Lab Ltd
BE786924A (fr) * 1971-07-28 1973-01-29 Squibb & Sons Inc Antibiotiques, leur preparation et leurs utilisations therapeutiques
US3796709A (en) * 1971-11-19 1974-03-12 Squibb & Sons Inc (alpha-cyanamino)acetamidocephalosporins
BE792229A (fr) * 1971-12-03 1973-06-01 Bristol Myers Co Agents antibacteriens heterocycliques azotes et procede pour les preparer
US3880842A (en) * 1972-05-30 1975-04-29 Squibb & Sons Inc Cephalosporin derivatives
US3988326A (en) * 1974-02-22 1976-10-26 Meiji Seika Kaisha, Ltd. Process for N-acylation of 7 amino cephem compounds

Also Published As

Publication number Publication date
KR830007681A (ko) 1983-11-04
AU548333B2 (en) 1985-12-05
ATE35813T1 (de) 1988-08-15
ES8206533A1 (es) 1982-08-16
IT1195762B (it) 1988-10-27
YU246381A (en) 1983-10-31
KR880000691B1 (ko) 1988-04-23
AU7624781A (en) 1982-04-22
EP0049928A3 (en) 1983-04-06
AR229035A1 (es) 1983-05-31
FR2491927A1 (fr) 1982-04-16
DK451281A (da) 1982-04-14
BE890718A (fr) 1982-02-01
CA1181741A (en) 1985-01-29
NO813433L (no) 1982-04-14
JPS5767583A (en) 1982-04-24
US4471115A (en) 1984-09-11
PT73807A (fr) 1981-11-01
FR2491927B1 (fr) 1985-07-12
IT8025267A0 (it) 1980-10-13
EP0049928B1 (en) 1988-07-20
EP0049928A2 (en) 1982-04-21
DE3176811D1 (en) 1988-08-25
PT73807B (fr) 1983-01-17

Similar Documents

Publication Publication Date Title
ES532765A0 (es) Procedimiento para preparar derivados de 3-bencilidenalcanfor
ES526381A0 (es) Procedimiento para preparar derivados de fenil-1-piperidino-2-propanol
ES502276A0 (es) Procedimiento para preparar derivados de piridoxina
ES505898A0 (es) Procedimiento para preparar derivados de pirimidona
AR227906A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-2-ciclohexen-1-alquilamina
ES522786A0 (es) Procedimiento para preparar derivados de piperacina.
ES501535A0 (es) Procedimiento para la preparacion de derivados de alquilfos-fonito
AR231289A1 (es) Procedimiento para preparar derivados de quinolil-4-1-piperidilo-4-2-etanol o quinolil-4-1-piperidil-4-3-propanol
MX6752E (es) Procedimiento para preparar derivados de carboestirilos
ES500796A0 (es) Procedimiento para preparar derivados de pirimidona
ES503407A0 (es) Procedimiento para la preparacion de derivados de pirimidina
ES499729A0 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol
MX157614A (es) Procedimiento para preparar derivados de isohexido
ES501736A0 (es) Procedimiento para la preparacion de derivados de 2-guanidi-notiazol
ES504787A0 (es) Procedimiento para la obtencion de derivados de diaril-imi- dazol
ES502649A0 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol substituidos
ES500892A0 (es) Procedimiento para la obtencion de derivados de bifeni- lil-azoliletano
ES499421A0 (es) Procedimiento para preparar derivados de indano
ES515567A0 (es) Procedimiento para preparar derivados de fenantreno.
ES505206A0 (es) Procedimiento para la obtencion de derivados de 1-azolil-bu-tano fluorados
AR229509A1 (es) Procedimiento para preparar derivados de 2-halogeno-acetanilidas
ES506213A0 (es) Procedimiento para preparar derivados metilolados de cefale-xina
ES505576A0 (es) Procedimiento para la preparacion de derivados de 7-oxopros-taciclina
ES504681A0 (es) Procedimiento para preparar derivados de 11- hidroxi-13 oxa-prostaglandina.
AR227341A1 (es) Procedimiento para preparar derivados de bis-aminometil-antraquinona